Invention Grant
US08367664B2 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
有权
取代的3-（5元不饱和杂环基-1,3-二氢 - 吲哚-2-酮及其衍生物作为激酶抑制剂
- Patent Title: Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
- Patent Title (中): 取代的3-（5元不饱和杂环基-1,3-二氢 - 吲哚-2-酮及其衍生物作为激酶抑制剂
-
Application No.: US11625852Application Date: 2007-01-23
-
Publication No.: US08367664B2Publication Date: 2013-02-05
- Inventor: Xialing Guo , Zhen Zhu , Thomas C. Malone
- Applicant: Xialing Guo , Zhen Zhu , Thomas C. Malone
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Krishna G. Banerjee; Joel German
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D403/14 ; A61K31/403 ; A61K31/496 ; A61P27/02 ; C07D405/04 ; C07D413/14 ; A61P3/10 ; A61P9/10 ; A61P17/06 ; A61P19/02 ; A61P25/00 ; A61P29/00 ; A61P35/00 ; A61P37/06
Abstract:
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
Public/Granted literature
Information query
